iQIYI (IQ) SVP reshapes multi-million share option awards via cancellations and regrants

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

iQIYI, Inc. senior vice president Duan Youqiao reported several administrative changes to stock options linked to Class A ordinary shares. Fully vested option awards for 3,200,000, 375,056 and 982,927 underlying shares at an exercise price of $0.5119 per share were canceled and regranted with a new expiration date of October 18, 2030, as described in the footnotes. The filing also shows remaining direct option holdings over 2,450,000 underlying shares at an exercise price of $0.00 and 2,275,000 underlying shares at $0.5119, both expiring on May 11, 2036.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Duan Youqiao

Role Senior Vice President

Type	Security	Shares	Price	Value
Disposition	Option (right to buy)	982,927	$0.00	--
Grant/Award	Option (right to buy)	982,927	$0.00	--
Disposition	Option (right to buy)	375,056	$0.00	--
Grant/Award	Option (right to buy)	375,056	$0.00	--
Disposition	Option (right to buy)	3,200,000	$0.00	--
Grant/Award	Option (right to buy)	3,200,000	$0.00	--
holding	Option (right to buy)	--	--	--
holding	Option (right to buy)	--	--	--

Holdings After Transaction: Option (right to buy) — 0 shares (Direct, null)

Footnotes (1)

The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 08/05/2016, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 08/05/2026) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

Key Figures

Amended options block 1: 3,200,000 underlying shares at $0.5119 Amended options block 2: 375,056 underlying shares at $0.5119 Amended options block 3: 982,927 underlying shares at $0.5119 +3 more

6 metrics

Amended options block 1 3,200,000 underlying shares at $0.5119 Options canceled and regranted; new expiration October 18, 2030

Amended options block 2 375,056 underlying shares at $0.5119 Options canceled and regranted; new expiration October 18, 2030

Amended options block 3 982,927 underlying shares at $0.5119 Options canceled and regranted; new expiration October 18, 2030

Remaining zero-price options 2,450,000 underlying shares at $0.0000 Direct options expiring May 11, 2036

Remaining $0.5119 options 2,275,000 underlying shares at $0.5119 Direct options expiring May 11, 2036

New vesting start date May 11, 2026 Reference date for four-year vesting schedules in footnotes

Key Terms

vesting, disposition to issuer, grant, award, or other acquisition, expiration date, +1 more

5 terms

vesting financial

"The options vest over a four-year period, with 25% vesting on the 1st anniversary"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

disposition to issuer financial

"transaction_code_description": "Disposition to issuer""

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

expiration date financial

"As amended, the options expire on 10/18/2030."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying security financial

"underlying_security_title": "Class A ordinary share""

Form 4 Insider Transactions: What Each Field Means →

05/13/2026 - 08:30 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duan Youqiao

(Last)

(First)

(Middle)

4F, IQIYI YOUTH CENTER, YOOLEE PLAZA,

NO. 21 NORTH ROAD OF WORKERS' STADIUM

(Street)

BEIJING

CHINA

100027

(City)

(State)

(Zip)

CHINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
iQIYI, Inc. [ IQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Senior Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Option (right to buy)	$0.5119							⁽¹⁾	05/11/2036	Class A ordinary share	2,275,000		2,275,000	D
Option (right to buy)	$0							⁽²⁾	05/11/2036	Class A ordinary share	2,450,000		2,450,000	D
Option (right to buy)	$0.5119	05/11/2026		D			982,927	⁽³⁾	08/05/2026	Class A ordinary share	982,927	⁽⁴⁾	0	D
Option (right to buy)	$0.5119	05/11/2026		A		982,927		⁽³⁾	10/18/2030	Class A ordinary share	982,927	⁽⁴⁾	982,927	D
Option (right to buy)	$0.5119	05/11/2026		D			375,056	⁽⁵⁾	02/14/2027	Class A ordinary share	375,056	⁽⁶⁾	0	D
Option (right to buy)	$0.5119	05/11/2026		A		375,056		⁽⁵⁾	10/18/2030	Class A ordinary share	375,056	⁽⁶⁾	375,056	D
Option (right to buy)	$0.5119	05/11/2026		D			3,200,000	⁽⁷⁾	02/28/2028	Class A ordinary share	3,200,000	⁽⁸⁾	0	D
Option (right to buy)	$0.5119	05/11/2026		A		3,200,000		⁽⁷⁾	10/18/2030	Class A ordinary share	3,200,000	⁽⁸⁾	3,200,000	D

Explanation of Responses:

1. The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

2. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.

3. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 08/05/2016, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

4. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 08/05/2026) and grant of new options. As amended, the options expire on 10/18/2030.

5. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

6. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.

7. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

8. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

	/s/ Duan Youqiao	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did iQIYI (IQ) report for Duan Youqiao?

The filing reports administrative option changes for Duan Youqiao. Existing fully vested options over 3,200,000, 375,056 and 982,927 underlying Class A shares were canceled and regranted with a new expiration date, without any open-market share purchases or sales disclosed.

Were the iQIYI (IQ) transactions in this Form 4 open-market buys or sells?

They were not open-market trades. The Form 4 shows option grants coded “A” and dispositions to the issuer coded “D,” reflecting cancellations and regrants of options rather than buying or selling iQIYI Class A shares in the public market.

What are the key terms of the amended iQIYI (IQ) stock options for Duan Youqiao?

The amended options relate to 3,200,000, 375,056 and 982,927 underlying Class A shares at an exercise price of $0.5119 per share. According to the footnotes, these options are fully vested and now expire on October 18, 2030 following the amendments.

How do the amended iQIYI (IQ) options for Duan Youqiao vest?

Footnotes explain the vesting schedules. For the amended awards, options vest over four years, with 25% vesting on the first anniversary of May 11, 2026 and the remaining 75% vesting in 12 equal quarterly installments starting one quarter after that anniversary date.

What ongoing option position does Duan Youqiao hold in iQIYI (IQ) after these transactions?

The derivative holdings table shows direct options over 2,450,000 underlying Class A shares at an exercise price of $0.00 and 2,275,000 underlying shares at $0.5119. Both series of options are shown with an expiration date of May 11, 2036.

Do the iQIYI (IQ) Form 4 footnotes explain why the options were amended?

Yes. The footnotes state that pairs of reported transactions involved amending outstanding options to extend the expiration date. Each pair is described as a deemed cancellation of options originally expiring in 2026–2028 and a grant of new options expiring on October 18, 2030.